Drawing on our established 5-year events in the series, the 6th LAFM returns for more content, new case-studies, 50+ speakers, and a brand-new track.
As the only peer led community for R and D operations leaders, from large pharma to start-ups, LAFM is your network to explore asset management and maintenance to help develop redundancy within budget, facility design to optimize space and expand research horizons, strategic sourcing across biopharma, and end-to-end R and D operations and EHS to support smaller-sized or growing biotech, institutes, hospitals, and healthcare organizations.
With the news of facility expansion from the likes of Vertex, Genentech and Novo Nordisk, juxtaposing a funding crunch time for biopharma, there's never been more responsibility put upon all lab operation professionals to ensure science can continue; whether you're optimizing resources or scaling out.
That's why the likes of COO, Cambridge at Eli Lilly, Head of Project Management Global Operations at Seagen and Chief of Staff at Interius Biotherapeutics and are joining the LAFM speaker faculty for the first time to help you benchmark best practices and find novel solutions, no matter your organization size or complexity.
Covering daily firefighting, to advanced strategies to help boost your lab sustainability, and digital transformation to facilitate your inventory tracking and procurement strategy, this is the only end-to-end meeting addressing holistic content coverage across lab operations, facilities, EHS, procurement and lab IT.
As the only peer led community for R and D operations leaders, from large pharma to start-ups, LAFM is your network to explore asset management and maintenance to help develop redundancy within budget, facility design to optimize space and expand research horizons, strategic sourcing across biopharma, and end-to-end R and D operations and EHS to support smaller-sized or growing biotech, institutes, hospitals, and healthcare organizations.
With the news of facility expansion from the likes of Vertex, Genentech and Novo Nordisk, juxtaposing a funding crunch time for biopharma, there's never been more responsibility put upon all lab operation professionals to ensure science can continue; whether you're optimizing resources or scaling out.
That's why the likes of COO, Cambridge at Eli Lilly, Head of Project Management Global Operations at Seagen and Chief of Staff at Interius Biotherapeutics and are joining the LAFM speaker faculty for the first time to help you benchmark best practices and find novel solutions, no matter your organization size or complexity.
Covering daily firefighting, to advanced strategies to help boost your lab sustainability, and digital transformation to facilitate your inventory tracking and procurement strategy, this is the only end-to-end meeting addressing holistic content coverage across lab operations, facilities, EHS, procurement and lab IT.
